CLUSTERING PROPERTIES OF BzK-SELECTED GALAXIES IN GOODS-N: ENVIRONMENTAL QUENCHING AND TRIGGERING OF STAR FORMATION AT z ~ 2 by LIN, LIHWAI, Dickinson, Mark, Jian, Hung-Yu, Merson, A I, Baugh, C M, Scott, Douglas, Foucaud, Sebastien, Wang, Wei-Hao, Yan, Chi-Hung, Yan, Hao-Jing

Get full text

The Nature of Faint Spitzer-selected Dust-obscured Galaxies by Pope, Alexandra, Bussmann, R. Shane, Dey, Arjun, Meger, Nicole, Alexander, David M, Brodwin, Mark, Chary, Ranga-Ram, Dickinson, Mark E, Frayer, David T, Greve, Thomas R, Huynh, Minh, Lin, Lihwai, Morrison, Glenn, Scott, Douglas, Yan, Chi-Hung

Get full text

CLUSTERING PROPERTIES OF B z K-SELECTED GALAXIES IN GOODS-N: ENVIRONMENTAL QUENCHING AND TRIGGERING OF STAR FORMATION AT z ∼ 2 by Lin, Lihwai, Dickinson, Mark, Jian, Hung-Yu, Merson, A. I., Baugh, C. M., Scott, Douglas, Foucaud, Sebastien, Wang, Wei-Hao, Yan, Chi-Hung, Yan, Hao-Jing, Cheng, Yi-Wen, Guo, Yicheng, Helly, John, Kirsten, Franz, Koo, David C., Lagos, Claudia del P., Meger, Nicole, Messias, Hugo, Pope, Alexandra, Simard, Luc, Grogin, Norman A., Wang, Shiang-Yu

Get full text

Clustering properties of BzK-selected galaxies in GOODS-N: environmental quenching and triggering of star formation at z ~ 2 by Lin, Lihwai, Dickinson, Mark, Hung-Yu, Jian, Merson, A I, Baugh, C M, Scott, Douglas, Foucaud, Sebastien, Wei-Hao, Wang, Chi-Hung, Yan, Hao-Jing, Yan, Yi-Wen, Cheng, Guo, Yicheng, Helly, John, Franz, Kirsten, Koo, David C, Claudia del P Lagos, Meger, Nicole, Pope, Alexandra, Simard, Luc, Grogin, Norman A, Messias, Hugo, Shiang-Yu, Wang

Get full text

The nature of faint Spitzer-selected dust-obscured galaxies by Pope, Alexandra, Bussmann, R Shane, Dey, Arjun, Meger, Nicole, Alexander, David M, Brodwin, Mark, Ranga-Ram Chary, Dickinson, Mark E, Frayer, David T, Greve, Thomas R, Huynh, Minh, Lin, Lihwai, Morrison, Glenn, Scott, Douglas, Chi-Hung, Yan

Get full text

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 by ACTIV-3/TICO LY-CoV555 Study Group

Request full text

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled... by Vock, David M., Vekstein, Andrew, Der, Tatyana, Filbin, Michael R., Rice, Todd W., Casey, Jonathan D., Sharifpour, Milad, Bakowska, Elizieta, Kowalska, Justyna, Hite, R. Duncan, Jain, Mamta K., Grandits, Greg, Polizzotto, Mark N., Jundgren, Jens D., Smolskis, Mary C., Voge, Susan E., McNay, Laura A., Cahill, Kelly, Kirchoff, Matthew, Mock, Rebecca, Zuckerman, Judith, Amos, Laura, Carter, Anita, Thompson, Greg, Marks, Mary E., Want, Samantha, Clariday, Laura, Fisher, Tammy, Palacious, Adriana, Whitacre, Heather, Bouffler, Andrew, Pappers, Brian, Preamble, Katarina, Bartolo, Elizabeth Berry, Baio, Kim T., Maton, Missy, Hutcheon, Douglass, Sher, Linda, Sharma, Aniket, Rodina, Valentina, Kadl, Alexandra, Fox, Ashley, Nossaman, Bobby, Laudun, Sylvia, Broussard, Shane, Rabin, Joseph, Saharia, Kapil, Shipman, Samantha, Parr, Doug, Bokhart, Gordon, Eichman, Sharon M., Ringwood, Nancy, Kardos, Cynthia, Talmor, Daniel, Banner-Goodspeed, Valerie, Peacock, Rebekah K., Yee, Kimberly J., Garcia, Rebekah L., Perez, Cynthia, McSparron, Jake I., Co, Ivan N., Wiedemann, Herbert P., More, Harshada, Roads, Tammy, Miller, Chadwick, Dhar, Sanjay, Johnson, Jakea, Gray, Christopher, Hays, Margaret, Vjecha, Michael, Petersen, Tianna, Gonzales, Sonia, Jibrell, Hodan, Klaphake, Jonathan, Vasudeva, Shikha, Hovmand, Nichlas, Kamstrup, Thobias, Bergsøe, Christina Marisa, Østergaard, Lars, Hertz, Mathias A., Lindnér, Cecilia Ebba Clara Ellinor, Havmøller, Signe Ravn, Exposito, Maria, Grüttner-Durmaz, Manuela, Horban, Andrzej, Virachit, Sophie, Ongko, Juwinda, Parmar, Mahesh KB, Kiweewa, Francis, Osinusi, Anu, Willis, Angela, Yan, Li, Bielica, Mona, Frye, Leanna, Galcik, Michael, Proffitt, Calvin, Smith, Kenneth, Murphy, Joseph, Flosi, Adam, Wenner, Christine

Get full text

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels: A Randomized Controlled Trial by ACTIV-3/TICO Bamlanivimab Study Group

Request full text

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19 by ACTIV-3/TICO Study Group

Request full text